Crohn's Disease after Proctocolectomy and IPAA for Ulcerative Colitis

Area of Science:

• Gastroenterology
• Colorectal Surgery
• Inflammatory Bowel Disease

Background:

• Proctocolectomy with ileal pouch-anal anastomosis (IPAA) is a curative treatment for ulcerative colitis (UC).
• However, Crohn's disease (CD) can manifest postoperatively in a subset of patients initially diagnosed with UC.

Purpose of the Study:

• To document the incidence of postoperative CD diagnosis after IPAA for UC.
• To identify preoperative predictors of CD development.
• To review the clinical course and management of patients who develop CD.

Main Methods:

• Retrospective cohort study of 301 patients undergoing IPAA for UC between 1985 and 2014 at a tertiary care center.
• Analysis of cumulative incidence of CD diagnosis over time.
• Identification of preoperative predictive factors using univariate and multivariate analyses.

Main Results:

• Crohn's disease was diagnosed in 12.6% of patients at a median of 77 months post-IPAA.
• Cumulative incidence of CD reached 7.5% at 5 years, 17.7% at 10 years, and 33.0% at 20 years.
• Significant preoperative predictors included current tobacco smoking, suspicion of indeterminate colitis, presence of mouth ulcers, and younger age at UC diagnosis.

Conclusions:

• Postoperative CD diagnosis after IPAA for UC is a significant long-term risk.
• Preoperative predictive factors are limited and should not preclude surgery.
• Medical management is effective for most patients, with pouch excision required in 16%.